GlassScriptPhysician profile
Nicholas J Beecroft
NPI 1104452275
$1,520.44
in general payments reported to CMS, 2019-2025
10 companies · $1,032 in 2025
The $1,032 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $14.44 · 2022: $51.76 · 2023: $278 · 2024: $145 · 2025: $1,032.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,354 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,354.25 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $693.01 | 2021-2025 | Spaceoar Vue System - 10ml, Lynx System, Solyx Sis System |
| Janssen Biotech, INC. | $252.70 | 2025 | Erleada, Carvykti, Rybrevant |
| Dendreon Pharmaceuticals LLC | $163.62 | 2025 | Provenge |
| Photocure INC | $110.51 | 2024-2025 | Cysview |
| Coloplast Corp | $91.39 | 2023 | Titan |
| Olympus America INC. | $91.35 | 2025 | Itind System |
| Endo Pharmaceuticals INC. | $35.97 | 2022-2023 | Xiaflex |
| Sumitomo Pharma America, INC. | $33.98 | 2025 | Gemtesa, Orgovyx |
| Calyxo, INC. | $31.50 | 2025 | Cvac Aspiration System |
| Pfizer INC. | $16.41 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicholas Beecroft listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.